Document:

QuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.3  

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

 
 

CLEARING SERVICES AGREEMENT  
    
    EFFECTIVE THE 16th DAY OF APRIL 2003    
    

BETWEEN  

CHICAGO
MERCANTILE EXCHANGE INC., a business corporation organized under the laws of the State of Delaware and having its principal office situated at 30 South Wacker Drive, Chicago, Illinois
60606 U.S.A., duly represented by its Chairman of the Board, Terrence Duffy, and by its President and Chief Executive Officer, James J. McNulty, (hereinafter referred to at times as "CME"), 

AND  

THE
BOARD OF TRADE OF THE CITY OF CHICAGO, INC., a non share corporation organized under the laws of the State of Delaware and having its principal office situated at 141 W. Jackson Blvd.,
Chicago, Illinois 60604 U.S.A., duly represented by its Chairman, Charles P. Carey, and by its President and Chief Executive Officer, Bernard W. Dan, (hereinafter referred to at times as
"CBOT"). 

Each
of CBOT and CME is referred to herein as a "Party", and collectively they are referred to as the "Parties." 

RECITALS:  

        WHEREAS, CME is registered with the Commodity Futures Trading Commission (the "CFTC") as a designated contract
market ("DCM") and a "derivative clearing organization" ("DCO") within the meaning of the Commodity Exchange Act, as amended (the "CEA"), and seeks to provide clearing services, as defined herein, for
CBOT futures and options contracts; 

        WHEREAS, CBOT is registered with the CFTC as a DCM and intends to register as a DCO within the meaning of the CEA, as amended, and seeks
to have CME provide clearing services, as defined herein, for CBOT futures and options contracts; 

        WHEREAS, the Parties intend to provide substantial benefits to their customers by clearing their listed contracts through the same
clearing house; 

        WHEREAS, the Parties intend to enhance the efficient use of capital by their members by employing CME's system of financial guarantees and
providing for more efficient portfolio risk margining of certain positions held at CME's clearing house; and 

        WHEREAS, the Parties intend to cooperatively promote the advantages of clearing certain CBOT products by means of CME systems, all on the
terms and subject to the conditions set forth in this Agreement. 

        NOW, THEREFORE, in consideration of the mutual covenants contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, and with the intent to be legally bound, the Parties hereby agree as follows: 

1.     INTERPRETATION  

	1.1.
	Definitions.  

In this Agreement, unless the context otherwise requires: 

	1.1.1.
	Agreement means the Clearing Services Agreement, effective as of April 16, 2003, by and between CME and CBOT. 

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	1.1.2.
	BOTCC shall have the meaning set forth in Section 7.3.

	1.1.3.
	CBOT Clearing Member means an individual or firm that meets CBOT's requirements to clear CBOT Products on or after the Effective
Date.

	1.1.4.
	CBOT Core Products means CBOT's U.S. Treasury, agricultural and federal funds based products as of the Effective Date.

	1.1.5.
	CBOT Data shall have the meaning set forth in Section 5.1.

	1.1.6.
	CBOT Products means all futures and futures options listed for trading on CBOT on the Launch Date or thereafter.

	1.1.7.
	CBOT Sole Proprietorship Clearing Member shall have the meaning set forth in Section 7.4.

	1.1.8.
	CEA shall have the meaning set forth in the first Recital.

	1.1.9.
	CFTC shall have the meaning set forth in the first Recital.

	1.1.10.
	Clearing Members means CBOT Clearing Members and/or CME Clearing Members, as the context requires.

	1.1.11.
	Clearing Services means the clearing, settlement and related services to be provided by CME under this Agreement, as further
described in Schedule A.

	1.1.12.
	Clearing Systems shall have the meaning set forth in Section 3.4.

	1.1.13.
	CME Clearing Member means an individual or firm that meets CME's requirements for clearing membership.

	1.1.14.
	CME Rules means CME's rules and clearing procedures, including interpretations and explanations.

	1.1.15.
	DCM shall have the meaning set forth in the first Recital.

	1.1.16.
	DCO shall have the meaning set forth in the first Recital.

	1.1.17.
	Dispute Notice shall have the meaning set forth in Section 19.4.

	1.1.18.
	Effective Date means April 16, 2003.

	1.1.19.
	EFS shall have the meaning set forth in Section 3.1.

	1.1.20.
	FCMs shall have the meaning set forth in Section 7.6.

	1.1.21.
	Indemnified Party shall have the meaning set forth in Section 16.1.

	1.1.22.
	Indemnifying Party shall have the meaning set forth in Section 16.1.

	1.1.23.
	Initial Term shall have the meaning set forth in Section 2.

	1.1.24.
	Launch Date means the first trading day for CBOT Products as to which transactions are required to be cleared through CME. The
Launch Date is the trading date of January 2, 2004.

	1.1.25.
	Market Participant means an individual or firm that engages in trading futures and options contracts.

	1.1.26.
	Material Breach means a breach of a provision of this Agreement that is material to a Party's obligations under the Agreement.

	1.1.27.
	Operational Policies and Procedures shall have the meaning set forth in Section 3.2. 

2

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	1.1.28.
	Party and Parties shall have the meaning set forth in the Preamble.

	1.1.29.
	Proprietary Business Information shall have the meaning set forth in Section 13.1.

	1.1.30.
	Renewal Term shall have the meaning set forth in Section 2.

	1.1.31.
	Replica CBOT Products shall have the meaning set forth in Section 6.4.

	1.1.32.
	Special CME Clearing Member means a CBOT Clearing Member that qualifies as a CME Clearing Member for purposes of clearing CBOT
Products pursuant to this Agreement, as set forth more fully in Section 7.

	1.1.33.
	Transition Clearing Services shall have the meaning set forth in Section 12.

	1.1.34.
	Transition Costs shall have the meaning set forth in Section 12.4.

	1.1.35.
	Term shall have the meaning set forth in Section 2.

	1.1.36.
	Unexcused Breach shall have the meaning set forth in Section 10.1.

 

	1.2.
	References. Unless something in the subject matter or context is inconsistent with the resulting interpretation, all references to
Sections and Schedules are to Sections and Schedules of this Agreement. The words "hereto", "herein", "of this Agreement", "under this Agreement" and similar expressions mean and refer to this
Agreement.

	1.3.
	Schedules. The Schedules forming part of this Agreement are as follows: 

	Schedule A	 	Clearing Services
	Schedule B	 	Fees
	Schedule C	 	Project Development Plan

	1.4.
	Headings. The inclusion of headings in this Agreement is for convenience of reference only and does not affect the construction or
interpretation of this Agreement.

 

	2.
	Initial Term; Renewal Term. This Agreement shall commence on the Effective Date and, unless terminated earlier in accordance with its
terms, shall terminate on January 10, 2008 (the "Initial Term"). Upon expiration of the Initial Term, this Agreement shall automatically renew for successive three-year renewal
terms (each a "Renewal Term") unless either Party notifies the other Party in writing at least six (6) months prior to the beginning of the applicable Renewal Term of its decision not to renew.
The Initial Term and the Renewal Terms, if any, are collectively referred to in this Agreement as the "Term". 

3.     Clearing Services.  

	3.1.
	Services Provided. Commencing with the Launch Date until the termination of this Agreement, whether at the end of the Initial Term or
any Renewal Term, each as specified in Section 2 above, and until expiration of any post-termination obligations, CME shall provide to CBOT the Clearing Services described in
Schedule A hereto. The Clearing Services shall be provided by CME with proper and reasonable care in conformance with the standards and procedures by which CME performs such services for its
listed contracts, except that trades matched by CBOT shall not be guaranteed until the matched trade record is received by CME. CBOT reserves the right to charge fees for post-trade
transactions and related services for CBOT Products even if CME does not now charge a fee for such transactions. Subject to the provisions of Section 3.10 respecting change request procedures
and payment of development cost, if applicable, CME agrees to facilitate the implementation of such charges, including providing CBOT access to CME's Exchange Fee System ("EFS"), and to provide CBOT
with any necessary data related to such policies and fees. CBOT shall pay CME for 

3

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	any
reasonable additional costs it may incur in providing data and other support to CBOT in response to a request authorized by this Section 3.1.

	3.2.
	Operational Policies and Procedures. CME's operational practices, policies and procedures related to implementing and performing
Clearing Services, including, without limitation, establishing marking prices that vary from settlement prices submitted by CBOT, where such settlement prices materially deviate from appropriate
market prices; the timeline for CME's receipt of information and data necessary to perform the Clearing Services and CME's delivery of information and data to CBOT, Clearing Members and other third
parties; data file formats; the manner in which CME makes information available to Clearing Members; and the mechanics of CME's automated delivery processes shall be the same as CME's existing
practices, policies and procedures, including the automated delivery system to be developed by CME as provided by Schedule A (collectively, the "Operational Policies and Procedures"), provided
that nothing in the Operational Policies and Procedures shall contravene any provision set forth in this Agreement.

	3.3.
	Fungibility and Cross-Margining of CBOT Products. CBOT shall have sole authority to determine (i) whether CBOT Products shall
be risk offset against other products pursuant to CME's portfolio margining policies or any cross-margining agreement and (ii) whether CBOT Products shall be made fungible, at the clearing
level, against products that are cleared by CME and listed for trading by CME, by another contract market, or by any other entity. CME may accept or reject any risk offset or fungibility arrangement
against products traded at CME that may be proposed by CBOT. CME shall support cross-margining of CBOT Products as set forth in Schedule A. CME support for cross-margining arrangements or
fungibility of CBOT Products other than as set forth above or in Schedule A shall be subject to the change request procedures set forth in Section 3.10, below.

	3.4.
	Clearing Systems. The systems owned by or licensed to CME that are utilized by CME in connection with providing Clearing Services are
referred to herein as the "Clearing Systems." CME shall pay to the appropriate software manufacturers, suppliers and distributors all license fees, royalties, use charges, taxes or other payments
associated with the Clearing Systems' intellectual property and technology utilized by CME in providing Clearing Services.

	3.5.
	CME Personnel. CME shall make available, at all times, a sufficient number of individuals who are properly qualified to perform and
who will perform the Clearing Services in accordance with this Agreement.

	3.6.
	Cooperation as to Development Work. The Parties acknowledge and agree that, after the Effective Date, they will be engaged in
development work as described in Schedule C hereto. The Parties agree to cooperate and use all reasonable efforts to perform the tasks necessary to complete such development work in accordance
with the time table set forth in Schedule C. CME shall be primarily responsible for such development work.

	3.7.
	Technical Cooperation. The Parties acknowledge that CME may have to incorporate new equipment into or modify its Clearing Systems in
ways that will require testing from time to time. Each Party acknowledges that, in implementing and testing such new equipment or modifications, it may require the technical assistance and cooperation
of the other, and both Parties agree to provide such assistance and cooperation. CBOT shall have the obligation of securing any necessary assistance of its third party providers.

	3.8.
	Backup and Disaster Recovery. CME will provide, as a part of the Clearing Services, backup and disaster recovery services and
procedures and functions for the Clearing Systems and 

4

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	the
Clearing Services using the backup and disaster recovery systems that CME employs for its own contracts.

	3.9.
	CME Modifications. CME may make modifications to the Clearing Systems and Clearing Services on its own initiative and at its own
expense as it may reasonably deem necessary or desirable, provided that any such modifications do not (i) materially increase CBOT's total costs of receiving the Clearing Services,
(ii) require CBOT to make material changes to its systems, software, or equipment other than with respect to changes made in the ordinary course of business, or (iii) violate the CEA,
applicable rules and regulations thereunder, or other applicable CFTC requirements. If any changes desired by CME would violate the conditions described in clauses (i) or (ii) above, CME
will obtain CBOT's written consent, which shall not be unreasonably withheld, prior to making any such change.

	3.10.
	Change Requests. CME will make modifications and enhancements to its Clearing Systems at the request and expense of CBOT, where such
changes are necessary to provide Clearing Services for a CBOT Product with characteristics significantly different from futures and futures options products traded as of the Effective Date or
additional cross margining arrangements, if in CME's sole judgment such changes will not impair functionality or materially increase operational costs. CBOT shall pay a commercially reasonable fee, to
be agreed in advance, to cover the cost of all such changes. All such requests will be addressed to a designated representative of CME's clearing house.

	3.10.1.
	CME response to requests. CME shall respond to requests from CBOT concerning modifications or enhancements to the Clearing Services
by evaluating the request, including the cost of the requested change and the impact of the requested change upon clearing services provided by CME as to other products and upon CME's technical
systems, and providing a response in accordance with this Section to CBOT concerning such request within thirty (30) days of CME's receipt of the request (unless the complexity of the request
reasonably requires a longer period, in which case CME shall provide an initial response).

	3.10.2.
	No material concerns. If CME reasonably determines in its sole judgment that the requested change will not materially impair
clearing services or materially increase operational costs to CME or CME Clearing Members, CME shall submit to CBOT a reasonably detailed proposal for implementing the change, which need not be
binding, and which shall include an estimate of the amount to be paid to CME for the requested change.

	3.10.3.
	Material concerns. If CME reasonably determines in its sole judgment that the requested change will materially impair functionality
or materially increase operational costs to CME or CME Clearing Members, CME may, but shall not be required to, submit to CBOT a reasonably detailed proposal for implementing the change, including
cost estimates, which need not be binding.

	3.10.4.
	Negotiations in good faith. In any case, the Parties shall negotiate in good faith as to any requested change and the terms of
CME's proposal, if any. Any change implemented by CME pursuant to this Section shall be made at the sole expense of CBOT at a commercially reasonable fee or upon any other financial basis to be agreed
upon between the Parties. Such financial arrangement may include upfront fees and/or modifications to the fee structure set forth in Schedule B. Except as otherwise agreed between CME and CBOT
in a writing that specifically purports to amend this Agreement and is executed by individuals with authority to do so, CME and/or its licensors, as applicable, shall own all right, title and interest
in any intellectual property created by the Parties in connection with any such implemented change that 

5

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	is
used by CME in connection with providing Clearing Services. CME will grant CBOT a license covering its free use of its contribution to any intellectual
property developed by CME.

 

	3.11.
	Assistance with Regulatory Matters. CME agrees to actively participate in, and make available sufficient human and technical
resources for, any submissions or presentations to, or meetings or discussions with, the staff of the CFTC respecting CME's provision of Clearing Services for CBOT Products. If CME reasonably
determines that CME's active participation in such submissions, presentations, meetings or discussions with the CFTC may result in the disclosure of CME's confidential or proprietary information, CBOT
will cooperate with CME to secure appropriate nondisclosure and confidentiality commitments from the CFTC prior to requiring CME's active participation in any such submissions, presentations, meetings
or discussions. 

4.     CBOT Payment of Fees and Expenses.  

	4.1.
	Generally. CBOT will pay fees for the Clearing Services provided by CME in accordance with this Agreement as set forth in
Schedule B hereto.

	4.2.
	Invoicing. CME shall invoice CBOT and CBOT shall pay such invoices as provided in Schedule B. If CME does not receive any
payment from CBOT in time required by schedule B, CME shall notify CBOT thereof and, if CBOT fails to pay such amount within fifteen (15) days of CBOT's receipt of such notice, CME may
declare CBOT in Material Breach of this Agreement and may thereafter exercise its rights set forth in Section 10.1 below.

	4.3.
	Initial Development Fee. CBOT shall reimburse CME for start-up costs incurred by CME in connection with preparations to
perform its obligations under this Agreement up to a maximum amount of $2 million. CME's start-up costs may include, without limitation, costs associated with hardware purchased;
software purchased, licensed, or developed internally; additional office space and other equipment required to support CME's operations on behalf of CBOT; and CME employee, consultant and independent
contractor time billed either at an actual rate per hour or reasonable average rate per hour (including reasonable benefits costs and allocation of overhead). Such start-up costs incurred
by CME shall be reimbursed by CBOT and such payments shall be non-refundable, without regard to termination of this Agreement for any reason. Such costs shall be billed monthly and
promptly paid.

	4.4.
	CBOT Costs of Formatting Data. CBOT shall be responsible for and bear any costs of formatting trading data for use by its compliance
and surveillance systems. 

5.     CME Intellectual Property.  

	5.1.
	CME Ownership. Subject to any different agreement between the Parties pursuant to Section 3.10.4, CME and its licensors, as
applicable, shall have sole and exclusive ownership of all right, title and interest in and to the intellectual property and technology developed or used by CME in connection with providing Clearing
Services. No provision of this Agreement shall be construed to bind or obligate CME in any way to develop, make further enhancements to or maintain any current or future version of the
Clearing 21® system software or any of the Clearing Systems, provided that CME agrees that it will provide to CBOT the same Clearing Services utilizing the same systems CME applies
to clearing the futures and options contracts traded on CME. 

6

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	5.2.
	CBOT Ownership of Data. As between CBOT and CME, any and all trading data, surveillance records, investigation reports and other
similar data or information created, generated, collected, or processed by CME in the performance of the Clearing Services ("CBOT Data") is and will remain the sole property of CBOT, and CME will and
hereby does, without additional consideration, assign to CBOT any and all right, title and interest that CME may now or hereafter possess in and to the CBOT Data. Except as provided below, CBOT Data
will not be utilized by CME for any purpose other than the performance of Clearing Services under this Agreement and will not be sold, assigned, leased or otherwise transferred, disposed of or
provided to third parties by CME or commercially exploited by or on behalf of CME.

	5.3.
	CME Delivery of CBOT Data. CME will promptly retrieve and deliver to CBOT a copy of all CBOT Data (or such portions as will be
specified by CBOT), in the format and on the media reasonably prescribed by CBOT, at CBOT's reasonable request from time to time. Upon termination of this Agreement or at the completion of any
requested Transition Clearing Services (whichever is later), if requested by CBOT, CME will destroy or securely erase all copies of the CBOT Data in CME's possession or under CME's control, except
that CME may retain copies of such CBOT Data for its appropriate regulatory and surveillance purposes.

	5.4.
	Protection of CBOT Data. CME will take those measures that CME takes to protect its own most confidential data of like kind, but not
less than reasonable measures: (i) to preserve the security of the CBOT Data; (ii) to prevent unauthorized access to or modification of any CBOT Data; and (iii) to establish and
maintain environmental, safety, facility and data security procedures and other safeguards against destruction, loss, alteration or theft of, or unauthorized access to, any CBOT Data.

	5.5.
	CME Use of CBOT Data. Notwithstanding CBOT's ownership of CBOT Data as described above, CME shall be free to use CBOT Data with
respect to the performance of the Clearing Services. 

6.     CBOT Contracts Subject to Clearing Services  

	6.1.
	Launch Date. On the Launch Date, CME shall commence clearing of all CBOT Products.

	6.2.
	CBOT Products. Except as otherwise specified in this Agreement, all CBOT Products shall be subject to this Agreement and shall be
cleared by CME, including any futures and options contracts traded at CME that CBOT also determines to list for trading. However, if a new CBOT Product requires changes to the Clearing Systems,
Section 3.10 shall govern the timing of CME's response to a notification by CBOT of such requested change. Products other than futures and futures options products may be cleared by CME as CBOT
Products under this Agreement only by mutual written agreement of the Parties.

	6.3.
	Notification to CME. CBOT shall notify CME of the classes and maturity dates of the CBOT Products that it intends to list for trading
in accordance with the Operational Policies and Procedures. CBOT shall also submit to CME in advance of listing any CBOT Product a copy of the contract specifications for the product, and shall
provide CME advance notice thereafter of any changes in contract specifications for the product.

	6.4.
	Replica CBOT Products. CME may offer and provide its clearing services to any exchange that lists for trading any product, including
CBOT Core Products where the underlying deliverable commodity is the same or substantially the same as in a CBOT Core Product ("Replica CBOT Products"). If CME determines to provide clearing services
for Replica CBOT Products traded or executed on any exchange other than CBOT, CME will notify 

7

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	CBOT
at the time CME agrees to provide clearing services for, or thirty (30) days before CME begins clearing, such Replica CBOT Products, whichever
is sooner. CBOT thereafter shall have ninety (90) days following receipt of such notice to determine whether to terminate this Agreement without penalty in light of such CME decision.

	6.5.
	Notices. Notwithstanding Section 19.5, notices required under this Section 6 may be delivered by e -mail or
through any other electronic method to which the Parties agree as a part of their operational discussions. 

7.     Admission of CBOT Clearing Members.  

	7.1.
	Generally. CME shall admit as Special CME Clearing Members all firms, including sole proprietorships, that were CBOT Clearing Members
as of the Effective Date. CME shall also admit as Special CME Clearing Members any firms that become CBOT Clearing Members after the Effective Date if such firms meet CME's requirements for clearing
members other than requirements respecting ownership of CME memberships or CME common stock. CBOT Clearing Members admitted as Special CME Clearing Members pursuant to this Agreement shall be
authorized to clear CBOT Products, to the extent permitted by CBOT as of the Effective Date. The rights of such individuals or firms as Special CME Clearing Members may not be assigned or transferred
voluntarily or by operation of law. For the avoidance of doubt, Special CME Clearing Members shall be permitted to clear other products cleared by CME only to the extent permitted by CME.

	7.2.
	Process for Admission. Following the Effective Date, CME shall, in consultation with CBOT, adopt rules for the admission of CBOT
Clearing Members as Special CME Clearing Members. Any CBOT Clearing Member admitted as a Special CME Clearing Member pursuant to Section 7.1 of this Agreement or under the rules adopted
pursuant to this Section 7.2 shall be considered to be admitted pursuant to this Agreement and shall be subject to all of the rules, requirements and obligations of CME's clearing house, other
than admission requirements, including ownership of CME memberships or CME common stock, and capital rules, except as hereinafter provided in this Section 7.

	7.3.
	Minimum Capital Rules. Any CBOT Clearing Member that is operating in compliance as of the Effective Date, and that continues to remain
in compliance through the Launch Date, with the Board of Trade Clearing Corporation ("BOTCC") rules respecting initial or admission capital requirements that are in effect on the Effective Date shall
be deemed to be in compliance with CME minimum capital rules on the Launch Date. After that date, CME may increase or decrease the capital requirements for any Special CME Clearing Member on an
individualized basis if the Special CME Clearing Member's risk profile changes materially, provided that CME may not, in any event, treat Special CME Clearing Members as a class or group for these
purposes. To the extent any Special CME Clearing Member that is not also a CME Clearing Member is required by CME to increase its minimum capital, such increase may be achieved through the acquisition
of additional CBOT memberships.

	7.4.
	Provisions for CBOT Clearing Members Joining After the Effective Date. Any CBOT Clearing Member that was not a CBOT Clearing Member as
of the Effective Date, but that becomes a Special CME Clearing Member thereafter, shall be subject to the following provisions with respect to capital requirements: (i) the CME capital
requirement for such Special CME Clearing Member will be equivalent to the BOTCC requirement that would have applied to such CBOT Clearing Member if it had been a CBOT Clearing Member on the Effective
Date, but (ii) CME may in its discretion require such Special CME Clearing Member to hold additional assets in an aggregate value equal to the difference between the 

8

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	CME
minimum capital requirement and the BOTCC capital requirement described in clause (i) above. If CME requires a Special CME Clearing Member to
hold additional assets as set forth in clause (ii) above, the assets allowed to be held in satisfaction of such requirement shall include CBOT memberships.

	7.5.
	Special Rules for CBOT Sole Proprietorship Clearing Members. Any CBOT Clearing Member that is a sole proprietorship ("CBOT Sole
Proprietorship Clearing Member") as of the Effective Date, admitted as a Special CME Clearing Member pursuant to this Section 7, shall be excused from compliance with the CME minimum capital
rules for the Initial Term of this Agreement, and shall be subject to no other minimum capital requirements imposed by CME provided that such CBOT Sole Proprietorship Clearing Member (i) was in
compliance with the BOTCC rules respecting initial or admission capital requirements that are in effect on the Effective Date, (ii) continues to operate in compliance with such BOTCC rules that
were in effect on the Effective Date, and (iii) does not materially change its risk profile (in which case a change in minimum capital requirements by CME shall be subject to the provisions of
Section 7.3). Any other CBOT Sole Proprietorship Clearing Member admitted as a Special CME Clearing Member shall be subject to special CME minimum capital rules that shall be agreed to by CME
and CBOT. After the Initial Term of this Agreement has expired, all CBOT Sole Proprietorship Clearing Members shall be subject to those special capital rules.

	7.6.
	Lien on CBOT Memberships. Each CBOT Clearing Member admitted hereunder as a Special CME Clearing Member shall execute in favor of CME
a lien against the CBOT membership interests required to be held by CBOT for clearing status, as of the Effective Date, to qualify as a CBOT Clearing Member or otherwise required to be held under
Section 7.4. The lien shall be the first lien against such membership interests following release of any prior lien held by BOTCC, which release shall be requested by the CBOT Clearing Member
promptly following the Launch Date. Each Special CME Clearing Member will be subject to a requirement to continue to hold at least the same number of CBOT memberships that CBOT required such Special
CME Clearing Member to hold for clearing member status as of the Effective Date.

	7.7.
	Audit of Non-FCM CBOT Clearing Members. CBOT shall periodically audit its Clearing Members that are not futures commission
merchants ("FCMs") and shall promptly share the results with CME's clearing house. 

8.     Transfer of CBOT Open Interest.  

	8.1.
	CBOT Rules. Promptly following the execution of this Agreement, CBOT shall draft and submit to the CFTC for approval rules that
provide for the clearing of CBOT Products at the CME clearing house, to the extent provided herein, and rules that will facilitate the transfer of open interest in CBOT Products from BOTCC to CME.
CBOT shall use its best efforts to ensure that such rules are approved by the CFTC reasonably in advance of the Launch Date, and CME shall use its best efforts to provide such assistance as CBOT may
request in securing such approval.

	8.2.
	CME Rules. Promptly following the execution of this Agreement, CME shall draft and submit to the CFTC for approval rules that provide
for the clearing of CBOT Products at the CME clearing house, to the extent provided herein, and that will facilitate the transfer of open interest in CBOT Products from BOTCC to CME. CME shall use its
best efforts to ensure that such rules are approved by the CFTC reasonably in advance of the Launch Date, and CBOT shall use its best efforts to provide such assistance as CME may request in securing
such approval. 

9

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	8.3.
	CME Margining of Positions. CME shall margin the positions so transferred prior to the opening of trading in CBOT Products on the
Launch Date, and the relevant Special CME Clearing Members shall be required to post the necessary performance bonds.

	8.4.
	CBOT Clearing Members. CME may require that, in order to participate in the transfer of open interest described in this Section, CBOT
Clearing Members that intend to become Special CME Clearing Members have completed CME's application process for Special CME Clearing Member status, have contributed to CME's security deposit pool,
and have established appropriate banking relationships by a date certain prior to the Launch Date. 

9.     Network Interconnections Between CBOT and CME  

	9.1.
	Facilities. CME shall establish and maintain an appropriate router or routers at CBOT for the purposes of (i) delivering data
to CME for clearing purposes, (ii) delivering data to CBOT for regulatory purposes, and (iii) exchanging data between the Parties for all other purposes required by this Agreement and
the Schedules hereto. CME shall establish and maintain appropriate telecommunications circuits between CBOT and CME as necessary to handle message flow and data delivery as set forth above. CBOT shall
provide computer room floor space and inside wiring for such routers and shall provide CME or any telecommunications provider with which it contracts for such services reasonable access for
maintenance and testing purposes.

	9.2.
	Outsourcing Permitted. CME may fulfill its obligation to establish and maintain the routers and telecommunications circuits described
in Section 9.1 through appropriate contractual arrangements with telecommunications service providers and/or other technology service providers.

	9.3.
	Financial Terms. CBOT shall be responsible for paying, via reimbursement to CME or direct billing, all third party or other direct
costs (not to include CME employee or CME independent contractor time) associated with the establishment and maintenance of the telecommunications circuits and routers described in Section 9.1,
provided that (i) where CME has a negotiated rate with an applicable telecommunications provider, CME shall attempt to secure for CBOT any preferential rate available under such contract, and
(ii) in no event shall the amounts paid by CBOT under this Section exceed the published tariff rate of the applicable telecommunications provider. Unless CME arranges for CBOT to be billed
directly by the applicable telecommunications provider, CME shall submit to CBOT an invoice for reimbursement of fees or other third-party costs actually paid by CME, and CBOT shall pay CME such
amounts no later than the final business day of the calendar month following the month in which CME invoices CBOT. 

10.   Breach of Agreement; Termination.  

	10.1.
	Breach of Agreement; Termination for Unexcused Breach. If either Party is in breach of this Agreement, the non-breaching
Party shall be required to provide written notice specifying such breach to the other Party, within five (5) business days of becoming aware of such breach, prior to submitting any Dispute
Notice under Section 19.4 or exercising any right to terminate as set forth in this Section 10.1. The breaching Party shall have thirty (30) days from receipt of such notice to
cure such breach. If the breaching Party cures such breach within such 30-day period, the right of termination or to submit a Dispute Notice shall expire and the breaching Party shall not
be subject to any further remedy or liability in respect of such breach. If the breaching Party does not cure such breach within such 30-day period, *****. 

10

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	10.2.
	Bankruptcy. Either Party may terminate this Agreement immediately upon the occurrence of any of the following events affecting the
other Party:

	10.2.1.
	Insolvency. The other Party admits its inability to pay its debts generally as they become due, or makes an assignment of
substantially all of its assets for the benefit of its creditors;

	10.2.2.
	Bankruptcy Filed. A proceeding in bankruptcy or for the reorganization of the other Party or for the readjustment of its debts,
under the United States Bankruptcy Code or any other State or Federal law for the relief of debtors now or hereafter existing, is commenced by or against the other Party and is not discharged within
sixty (60) days of commencement; or

	10.2.3.
	Receiver Appointed. A receiver or trustee is appointed in a bankruptcy proceeding for the other Party or for any substantial part
of its assets, or any proceedings are instituted for the dissolution or the full or partial liquidation of such Party, and such receiver or trustee is not discharged within sixty (60) days of
his or her appointment or such proceedings are not discharged within sixty (60) days of their commencement, as the case may be.

 

	10.3.
	*****.

	10.4.
	*****.

	10.5.
	CME Termination If Rules Not Approved. If the CFTC fails to approve the rules that will allow CME to perform the Clearing Services by
July 15, 2003, then CME may, within thirty (30) days at its sole discretion, terminate this Agreement (by August 15, 2003) by written notice to CBOT, without application of any
cure period, unless the CFTC has approved such rules before CME exercises its right to terminate. Termination by CME pursuant hereto shall not constitute a breach by either Party. If CME does not
exercise its right to terminate, then the Agreement shall continue according to its terms.

	10.6.
	Legal Or Regulatory Matters. If either Party is precluded from performing its obligations under the Agreement by statute, regulation
or legal action of any governmental agency, including failure of the CFTC to approve necessary rules (including rules necessary to transfer the open interest) by the Launch Date, either Party may
terminate this Agreement by written notice, without application of any cure period, and upon such termination both Parties shall be excused, without penalty or liquidated damages, from any further
performance under the Agreement. If the Parties elect not to terminate this Agreement, they shall renegotiate in good faith the Launch Date, the Initial Term and payment of CME's costs of continuing
to be prepared to begin performance under this Agreement..

	10.7.
	*****.

	10.8.
	CME Provision of Clearing Services for Replica CBOT Products. Section 6.4 shall govern the respective rights of the parties if
CME notifies CBOT that CME will offer clearing services for Replica CBOT Products.

	10.9.
	Inability to Meet Launch Date. If CME's provision of services under this Agreement on the Launch Date is deficient to an extent that
prevents CBOT from operating its exchange for a substantial portion of the trading day on the Launch Date due solely or primarily to failures or problems that were within CME's ability to prevent or
mitigate, failure to perform shall be CME's responsibility and shall constitute a Material Breach by CME. In such case, within five (5) business days thereafter CBOT may either (i) seek
to terminate this Agreement by exercising its rights as set forth in Section 10.1, or (ii) without application of any provision of Section 10.1, including any cure period, file a
Dispute Notice and pursue a 

11

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	claim
for damages, provided that any such claim for damages shall be subject to the special limitation of liability set forth in the first sentence of
Section 15.1. If CME's provision of services under this Agreement on the Launch Date is deficient to an extent that prevents CBOT from operating its exchange for a substantial portion of the
trading day on the Launch Date due solely or primarily to failures or problems that were within CBOT's ability to prevent or mitigate, and CBOT failed to prevent or mitigate such failures or problems
despite receiving notice from CME concerning the risk of failing to meet the Launch Date, then the failure to perform shall be the responsibility of CBOT and shall constitute a Material Breach by
CBOT, which shall trigger CME's rights under Section 10.1. For purposes of this Section 10.9, a failure by CBOT's electronic trade matching facility service provider that was within such
service provider's ability to prevent or mitigate shall be deemed a failure by CBOT. In any situation described in this Section 10.9 and throughout any applicable cure period, the Parties shall
remain in regular communication concerning the failure at issue, and the breaching Party shall give prompt notice to the other Party if it determines that it will not cure the breach within the cure
period.

	10.10.
	Joint Press Release. If either Party terminates this Agreement prior to or immediately following the Launch Date, the Parties shall
work together to issue a joint press release and, if appropriate, hold a joint press conference, concerning the termination of the Agreement.

	10.11.
	Break-up Fees Reasonable. The Parties agree that the liquidated damages and break-up fees set forth in this
Section 10 represent a reasonable measure of damages to CME or CBOT, as the case may be, under the circumstances resulting in such termination. The Parties agree that calculating the measure of
damages to either Party under the circumstances under which break-up fees are to be paid would be extremely difficult given the complexities of the business arrangements, the uncertainty
of the revenues to be earned by either Party through the arrangements set forth in this Agreement, and the uncertainty of the value of opportunities that will have been lost by the terminating Party
under the circumstances.

	10.12.
	Action for Damages. For the avoidance of doubt, either Party may bring an action for damages against the other Party alleging any
breach of this Agreement (except where an alleged breach has been cured, as described in Section 10.1) in lieu of invoking any right to terminate and receive agreed liquidated damages as
described in any provision of Section 10. Any such action for damages shall be subject to the applicable limitation of liability set forth in Section 15.1 or Section 15.2.

 

	11.
	Limited Right to Continuance of Clearing Services. Notwithstanding any other provision of this Agreement, upon termination of this
Agreement for any reason, if CBOT is unable to engage another entity prepared and able to provide services comparable to the Clearing Services on commercially reasonable terms, CBOT shall have the
right to require that CME continue providing any or all of the Clearing Services, as set forth below. For the avoidance of doubt, pricing terms generally shall be deemed commercially reasonable, and
alternate services generally shall be deemed comparable, if such terms and services are reasonably similar to those accepted by other parties receiving services from other clearing services providers.

	11.1.
	Six-Month Continuation Period. In the event that (i) this Agreement is terminated by CME as a result of an
Unexcused Breach by CBOT, (ii) CBOT elects not to renew this Agreement pursuant to Section 2 above, or (iii) this Agreement is terminated for any other reason except those
described in Section 11.2, CBOT may require that CME continue to provide Clearing Services after the termination of this Agreement or expiration of the Initial Term or Renewal Term of this
Agreement, as the case may be, for 180 days.

	11.2.
	One-Year Continuation Period. In the event that (i) this Agreement is terminated by CBOT as a result of an
Unexcused Breach by CME, (ii) this Agreement is terminated by CBOT 

12

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	pursuant
to Section 6.4, or (iii) CME elects not to renew this Agreement pursuant to Section 2 above, CBOT may require that CME
continue providing Clearing Services after the termination or expiration date, as the case may be, for up to one (1) year.

	11.3.
	Payment of Fees. In the event that CBOT requires CME to continue to provide all or substantially all of the Clearing Services
pursuant to this Section 11, CBOT shall pay CME for these Clearing Services at the fees set forth in Schedule B. In the event that this Agreement is terminated by CME for nonpayment of
fees, bankruptcy or insolvency, or if CBOT fails to timely pay fees during the continuation period, CME shall not be required to continue to provide Clearing Services unless CBOT pays CME monthly in
advance for the continued provision of such Clearing Services based upon a reasonable estimate of the amounts likely to be due in respect of each month. CME agrees to credit back to CBOT any estimated
amounts paid by CBOT that are later determined to be over-payments by CBOT.

	11.4.
	Notice to CME. If CBOT elects to require the continuation of any Clearing Services under this Section 11, then CBOT shall give
at least ninety (90) days prior written notice to CME of the date for cessation of such continuation of Clearing Services.

	11.5.
	Hold Over by CBOT. If CBOT is unable to transfer to another provider of clearing services at the conclusion of any of the periods
provided above for the limited continuation of Clearing Services, CME shall continue to provide the Clearing Services. During the period that CME provides clearing services under this
Section 11.5, CBOT shall pay a fee of ***** plus all additional costs incurred by reason of CBOT's failure to transfer to another DCO, including without limitation any necessary retention
bonuses or employment benefits or fees, in addition to the fees set forth in Schedule B, for each month that it holds over.

	11.6.
	Continuation is Not Renewal. Continuation of Clearing Services under this Section 11 shall not be deemed a renewal of this
Agreement under Section 2 beyond the termination date.

 

	12.
	Transition Clearing Services. In connection with the termination of this Agreement for any reason or expiration of the Initial Term or
Renewal Term of this Agreement, as the case may be, and in order to assist CBOT in terminating the Clearing Services and transitioning such services to another entity in an orderly manner, CME shall,
if and as requested by CBOT, provide the following services (the "Transition Clearing Services"):

	12.1.
	Transition Plan. CME and CBOT shall cooperate to prepare a transition plan setting forth the respective tasks to be accomplished by
each Party in connection with the transition and a schedule pursuant to which such tasks are to be completed;

	12.2.
	Necessary Date. CME shall provide CBOT with all data and other information maintained by CME necessary to transfer responsibility for
providing the Clearing Services to another entity as of the date services are no longer rendered by CME and all hardcopy records relating to other CBOT Data maintained by CME, except that CME may
retain copies of such data and other information for its appropriate regulatory and surveillance purposes; Such data and other information shall be provided to CBOT on magnetic tape or such other
storage medium, and in such format, reasonably acceptable to CBOT;

	12.3.
	Transfer of Positions. CME shall transfer any open positions in CBOT Products from CME to the new DCO selected by CBOT in accordance
with directions CME shall receive from CBOT for such transfer; and

	12.4.
	Reimbursement of Costs. CBOT shall pay or reimburse CME for any and all costs ("Transition Costs") reasonably and actually incurred
by CME that are directly attributable to providing Transition Clearing Services in accordance with this Section 12 (with the rates 

13

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	for
any CME employees used to perform such Clearing Services reasonably reflecting CME's fully loaded costs with respect to such employees, plus a
commercially reasonable profit margin); provided that CME shall act in good faith and use commercially reasonable efforts to minimize and mitigate any Transition Costs. 

13.   Confidentiality.  

	13.1.
	Generally. CBOT and CME each acknowledges that it will receive during the term of this Agreement confidential or proprietary
information of the other Party relating to the Clearing Services and Clearing Systems. (All such information is collectively referred to in this Agreement as "Proprietary Business Information.")
Materials embodying such information and within the scope of this Section 13.1 shall bear reasonable legends to such effect to the extent appropriate. Each Party agrees to take reasonable steps
to maintain the confidentiality of the Proprietary Business Information of the other Party, and each Party agrees to use such information only in connection with the performance of its obligations and
the exercise of its rights under this Agreement and for appropriate regulatory and surveillance purposes. In the event that this Agreement is terminated for any reason, each Party agrees that it shall
use reasonable efforts to return to the other Party or destroy all Proprietary Business Information of the other Party in its possession in tangible form and that it shall not knowingly retain any
copies thereof, except that each Party may retain copies of the other Party's Proprietary Business Information for its appropriate regulatory and surveillance purposes.

	13.2.
	Exclusions. In no event shall the provisions of this Section 13 apply to any information that: (i) was rightfully known
to the receiving Party prior to its receipt from the disclosing Party, or becomes rightfully known to the receiving Party other than as a result of the relationship between the Parties pursuant to
this Agreement; (ii) is or becomes public knowledge through no fault of the receiving Party; (iii) is disclosed to the receiving Party by a third Party with the right to disclose the
information without restriction or subject to restrictions to which the receiving Party has conformed; or (iv) is independently developed by the receiving Party without use of any confidential
or proprietary information of the disclosing Party. Notwithstanding anything in Section 13.1 above to the contrary, each Party may disclose any Proprietary Business Information received by it
to the extent that it is required by subpoena or other order of court, law or other regulation, or required or requested by any governmental or regulatory authority having jurisdiction or required
pursuant to an information sharing agreement, rule, or policy with another self-regulatory body, to furnish such Proprietary Business Information to any third Party, or as otherwise
permitted in this Agreement; provided that, in any such case, the receiving Party shall provide the disclosing Party with prompt notice thereof so that the disclosing Party may seek an appropriate
protective order. In the absence of a protective order, if the receiving Party is nonetheless, in the opinion of its counsel, compelled to furnish Proprietary Business Information to any third Party
or else stand liable for contempt or suffer other censure or penalty, such Party may furnish such information without liability under this Section 13 or otherwise.

 

	14.
	Force Majeure. Each Party shall be excused from performance under this Agreement and shall have no liability to the other Party to the
extent that, and for any period during which, it is prevented from performing any of its obligations hereunder as a result of any act, or failure to act, of the other Party or by an act of God, war,
civil disturbance, act of terrorism, court order (except as provided in Section 10), or other cause beyond its reasonable control (including, without limitation, failures or fluctuations in the
electrical or mechanical equipment, communication lines, heat, light or telecommunications, in each case to the extent beyond its reasonable control), 

14

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	provided
that each party agrees to apply fully its disaster recovery system to minimize any reduction in service it has agreed to provide under this
Agreement. 

15.   Liability Limits; Indemnification.  

	15.1.
	CME. *****. Notwithstanding the foregoing, but subject to the provisions of Section 16 below, CME shall indemnify, defend and
hold harmless CBOT and its directors, officers, employees and agents, in accordance with the procedures described in Section 16.1 below, from and against any and all losses, liabilities,
damages and claims, and all related costs and expenses (including without limitation reasonable attorneys' fees), arising from the willful misconduct on the part of CME, its directors, officers,
employees or agents.

	15.2.
	CBOT. *****. Notwithstanding the foregoing, but subject to the provisions of Section 16 below, CBOT shall indemnify, defend
and hold harmless CME and its directors, officers, employees and agents, in accordance with the procedures described in Section 16.1 below, from and against any and all losses, liabilities,
damages and claims, and all related costs and expenses (including without limitation reasonable attorneys' fees), arising from the willful misconduct on the part of CBOT, its directors, officers,
employees or agents. 

16.   Indemnity  

	16.1.
	Procedure. If any third Party notifies either Party (the "Indemnified Party") with respect to any matter which may give rise to a
claim for indemnification against the other Party (the "Indemnifying Party"), then the Indemnified Party shall promptly notify the Indemnifying Party thereof; provided, however, that no delay on the
part of the Indemnified Party in notifying the Indemnifying Party shall relieve the Indemnifying Party from any liability or obligation hereunder, except to the extent (if any) that the Indemnifying
Party is damaged by such delay. If the Indemnifying Party notifies the Indemnified Party that it is assuming the defense of any claim:

	16.1.1.
	Defense of Claim. The Indemnifying Party shall defend the Indemnified Party against such claim with counsel of its choice
reasonably satisfactory to the Indemnified Party;

	16.1.2.
	Separate Co-counsel Permitted. The Indemnified Party may retain separate co-counsel at its sole cost and
expense (except that the Indemnifying Party shall be responsible for the fees and expenses of the separate co-counsel to the extent that the Indemnified Party concludes reasonably that the
counsel the Indemnifying Party has selected has a conflict of interest);

	16.1.3.
	Consent Decree or Settlement. The Indemnified Party shall not, without foregoing the benefits of this Section 16.1, consent
to the entry of any judgment or enter into any settlement with respect to such claim without the prior written consent of the Indemnifying Party, which consent shall not be unreasonably withheld or
delayed; and

	16.1.4.
	Full Release. The Indemnifying Party shall not consent to the entry of any judgment with respect to the matter or enter into any
settlement which does not include a provision whereby the plaintiff or claimant releases the Indemnified Party from any and all responsibility and liability with respect to such claim, without the
prior written consent of the Indemnified Party.

 

	17.
	Consequential and Punitive Damages. *****. 

15

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

18.   Public Announcements.  

	18.1.
	Requirements Generally. CME and CBOT each agree that it will not issue any public announcement concerning CME's provision of Clearing
Services, the terms of this Agreement, the negotiations between CME and CBOT leading up to and following the execution of this Agreement, or any other matter related in any way to this Agreement that,
for each Party, involves the other Party, without (i) consulting with the other Party prior to issuing the announcement so that such announcements may be issued jointly, if appropriate;
(ii) providing the other Party an advance copy of the proposed press release or other announcement not later than three (3) business days prior to its release; and (iii) in the
case of public appearances by directors, officers or other officials associated with a Party at which any of the foregoing matters are likely to be discussed, providing advance notice to the other
Party of such appearance and, if possible, extending an invitation to the other Party for a representative of its own to be included in such appearance.

	18.2.
	Definition. For purposes of this Section, a "public announcement" shall include, without limitation, (i) any press release,
press statement or press conference, (ii) any brochures or notices to be delivered or made available to the public generally (including marketing materials), and (iii) any notice to be
circulated to Clearing Members or Market Participants, that, in each case, includes or may include material information that has not previously been released about the terms of or negotiations
surrounding this Agreement or the relationship between CME and CBOT that is established through this Agreement.

	18.3.
	Joint Press Releases, Statements and Conferences. Notwithstanding the foregoing, the Parties shall use their best efforts to ensure
that any press release, press statement or press conference the primary topic of which concerns this Agreement or the relationship between CME and CBOT shall be a joint press release, press statement
or press conference. 

19.   Miscellaneous.  

	19.1.
	Benefits of Agreement. This Agreement shall be binding upon, and inure to the benefit of, the Parties hereto and their respective
successors. Except to the extent provided in Sections 15.1 and 15.2 above with respect to the directors, officers, employees and agents of CBOT and CME, respectively, nothing in this Agreement,
express or implied, shall give to any other person or entity any benefit or any legal or equitable right or remedy.

	19.2.
	Waiver. Except as expressly provided herein, neither Party shall, by mere lapse of time, without giving notice or taking any other
action, be deemed to have waived any breach by the other Party of any of the provisions of this Agreement.

	19.3.
	Governing Law. This Agreement shall be construed and enforced in accordance with the laws of the State of Illinois (other than the
laws thereof that would require reference to the laws of any other jurisdiction).

	19.4.
	Dispute Resolution. A Party shall not commence a litigation proceeding against the other Party unless that Party first gives written
notice to the other Party setting forth the nature of the dispute ("Dispute Notice"). The Parties shall attempt in good faith to resolve the dispute by mediation with a mediator selected by mutual
agreement of the Parties. If the Parties cannot agree on the selection of a mediator within twenty (20) days after delivery of the Dispute Notice, or if the dispute has not been resolved by
mediation as provided by this Section 19.4 within sixty (60) days after the delivery of the Dispute Notice, then either Party may commence litigation. The state courts of the County of
Cook, Illinois and the United States District Court for the Northern District of Illinois shall have the exclusive jurisdiction over any and all litigated claims arising out of or relating to this
Agreement or the subject 

16

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	

	matter
hereof. Each of the Parties hereby irrevocably (i) submits to the personal jurisdiction of such courts over such Party in connection with any
litigation, proceeding or other legal action arising out of or in connection with this Agreement or the subject matter hereof, (ii) waives to the fullest extent permitted by law any objection
to the venue of any such litigation, proceeding or action which is brought in any such court, and (iii) agrees to the mailing of service of process to the address specified below for such Party
as an alternative method of service of process in any legal proceeding brought in any such court.

	19.5.
	Notices. All communications or notices required or permitted to be given under this Agreement shall be sufficiently given for all
purposes hereunder if given in writing and (i) delivered personally, (ii) deposited in the United States mail, postage prepaid and return receipt requested, (iii) delivered by a
recognized document overnight delivery service or (iv) sent by telecopy, facsimile or other electronic transmission service (provided a confirmation of delivery is received). All notices
delivered in accordance with this Section 19.5 shall be sent to the appropriate address or facsimile number set forth below, or to such other address or facsimile number or to the attention of
such other person as the recipient Party may have specified by prior written notice to the sending Party. 

	CME Contact	 	CBOT Contact
	

Mr. Craig Donohue

Executive Vice President and Chief Administrative Officer

Chicago Mercantile Exchange Inc.

30 South Wacker Drive

Chicago, Illinois 60606

Facsimile No.: 312-930-3323	
 	

Ms. Carole Burke

Executive Vice President, Chief of Staff and General Counsel

CBOT

141 W. Jackson Blvd

Chicago, Illinois 60604

Facsimile No.: 312-341-3392

	19.6.
	Severability. If any provision of this Agreement is deemed to be illegal or unenforceable by any court of competent jurisdiction,
(i) such provision shall be deemed to be severable from the remainder of this Agreement, (ii) the effect of such determination shall be limited to such provision to the extent reasonably
practicable, and (iii) the validity, legality and enforceability of such provision in any other jurisdiction shall not in any way be affected or impaired thereby.

	19.7.
	Amendments. No provision of this Agreement may be amended, modified, supplemented or waived, except by an agreement in writing
executed and delivered by authorized representatives of both Parties.

	19.8.
	Entire Agreement. This Agreement, including the Schedules hereto, constitutes the entire agreement and understanding, and supersedes
any and all prior agreements and understandings, whether written or oral, between the Parties with respect to the subject matter hereof.

	19.9.
	Relationship of Parties. CME, in providing the Clearing Services, is acting only as an independent contractor. Except as expressly
provided in this Agreement or any other agreement to which CME and CBOT are parties, CME does not undertake to perform any obligations of CBOT, whether regulatory or contractual, or to assume any
responsibility for the business or operations of CBOT.

	19.10.
	Counterparts. This Agreement may be executed in one or more counterparts, each of which when so executed shall be an original, but
all of which together shall constitute but one and the same instrument. 

17

 

Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated
by asterisks ("*****"), and the omitted text has been filed separately with the Securities and Exchange Commission. 

	19.11.
	Assignment. This Agreement may not be assigned in whole or in part by either Party hereto without the prior written consent of the
other Party hereto. CBOT may assign this Agreement and its rights and obligations hereunder to an entity to which CBOT is selling all or substantially all of its assets without the prior written
consent of CME. The consummation of the transactions contemplated by CBOT's proposed restructuring shall not be deemed to be such an assignment or sale for purposes of this Agreement. CME may assign
this Agreement and its rights and obligations hereunder, in their entirety, to an entity to which CME is selling all or substantially all of its clearing assets without the prior written consent of
CBOT.

	19.12.
	Survival. Following any termination of this Agreement in accordance with its terms and the expiration of the
post-termination obligations of CME pursuant to Sections 11 and 12 hereof, all obligations hereunder of each Party to the other shall terminate and (without limiting the generality
of the foregoing) CME shall have no further obligation to provide Clearing Services to CBOT. Notwithstanding the foregoing, however, the provisions of Sections 13, 15, 16 and 17 of this
Agreement (including this Section 19.12) shall survive and remain in effect following any termination of this Agreement in accordance with its terms and the expiration of the
post-termination obligations of CME. 

18

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

        IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized representatives as of the date first
above written. 

	CHICAGO MERCANTILE EXCHANGE INC.	 	THE BOARD OF TRADE OF THE CITY OF CHICAGO, INC.
	

By:	
 	

/s/  TERRENCE A. DUFFY      
 Terrence A. Duffy,

Chairman of the Board, CME	
 	

By:	
 	

/s/  CHARLES P. CAREY      
 Charles P. Carey

Chairman of the Board, CBOT
	 	 	Date:	 	    
	 	 	 	Date:	 	    

	

By:	
 	

/s/  JAMES J. MCNULTY      
 James J. McNulty

President and Chief Executive Officer	
 	

By:	
 	

/s/  BERNARD W. DAN      
 Bernard W. Dan

President and Chief Executive Officer
	 	 	Date:	 	    
	 	 	 	Date:	 	    

19

   Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated
by asterisks ("*****"), and the omitted text has been filed separately with the Securities and Exchange Commission. 

SCHEDULE A

DESCRIPTION OF CLEARING AND SETTLEMENT SERVICES  

        In accordance with the terms of this Agreement, CME shall provide clearing services as follows with respect to transactions in CBOT Products: 

Electronic Trade Acceptance.    CME shall accept for clearing and guarantee matched trades submitted to CME by CBOT (or CBOT's electronic
trade matching facility service provider) in accordance with the CME Rules and the Operational Policies and Procedures in effect from time to time. 

Pit Trade Acceptance—Electronic Devices.    CME shall receive unmatched trade records submitted to CME by CBOT from electronic pit
trading technology devices, and CME shall accept for clearing and guarantee such trades upon matching by CME in accordance with the CME Rules and the Operational Policies and Procedures in effect from
time to time. 

Pit Trade Acceptance—Open Outcry.    CME shall receive unmatched trade records submitted to CME by Special CME Clearing Members
for trades executed without benefit of electronic pit trading technology devices, and CME shall accept for clearing and guarantee such trades upon matching by CME in accordance with the CME Rules and
the Operational Policies and Procedures in effect from time to time. 

Ex-Pit Trade Acceptance.    CME shall receive unmatched trade records submitted to CME by Special CME Clearing Members for
ex-pit trades (blocks and EFPs) that are executed in accordance with CBOT rules, and CME shall accept for clearing and guarantee such trades upon payment of initial settlement variation
and performance bond by the applicable settlement bank for each party to the transaction, as set forth in the CME Rules and the Operational Policies and Procedures in effect from time to time. 

Requirements for CME Trade Acceptance.    In addition to the other requirements that may be set forth in this Agreement, the CME Rules and the
Operational Policies and Procedures, the following requirements apply to CME's receipt and acceptance for clearing of trades as set forth in this Schedule A: 

Origins for Matched and Unmatched Trade Records.    CME will support up to four origins for transactions in CBOT Products—house,
house market-maker, customer, and customer market-maker—subject to final confirmation by CBOT promptly following the effective date. 

Report Formats.    Message formats for trade records, including but not limited to, trade registers, out-trade and EQC reports,
and brokers' matched and unmatched trade reports shall conform to CME specifications. 

Opposite House Switches.    CME will not support the current modified contra matching practice currently employed by BOTCC with respect to
unmatched trades in CBOT products. However, CME will facilitate matching of unmatched trades by performing automatic opposite house switches for unmatched trades in CBOT products, as CME does for
unmatched trades in its own products, in accordance with the CME Rules and the Operational Policies and Procedures. CME will explore the functional requirements for integrating modified
contra-matching processes as a possible enhancement after the Launch Date. 

SLEDs.    CME will not support single-line spread entry functionality ("SLEDs") as of the Launch Date. CME will use reasonable
efforts, in consultation with CBOT, to implement SLEDs for transactions in CBOT products by February 20, 2004. 

A-1

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

Position Maintenance and Settlement.    On a daily basis CME shall calculate and collect original margin, premium and variation margin on
futures and options trades and positions in the accounts of Special CME Clearing Members. CME shall settle the gains and losses associated with futures and options trades and positions in the accounts
of clearing members at least once each business day, typically twice each business day, and more frequently as CME determines is warranted by market volatility. 

CME PCS Process.    CME's position change submission (PCS) process will be used for reporting final positions and spreadable positions and to
determine each clearing member's final position for margining purposes and for exercise and assignment of options, as well as for determining the exchange open interest to be reported for each
business day. 

Net Margining of CBOT Products.    CME will support net margining of positions in CBOT Products in substantially the same manner as the
current procedures employed by BOTCC with respect to performance bond requirements. Notwithstanding the foregoing, CME may adjust formulas for calculating security deposit
requirements or assessment of security deposit contributions with respect to net-margined products, as CME in its reasonable discretion deems appropriate in order to fairly and equitably
calculate security deposit requirements, given differences between positions subject to gross margining and positions subject to net margining. 

SPAN Files.    CME will generate and distribute to Special CME Clearing Members' and customers' SPAN files reflecting SPAN margining of
positions in CBOT Products. SPAN files will be distributed over the internet and through any other means specified in the CME Rules and the Operational Policies and Procedures. CME may generate and
distribute joint SPAN files for positions in CBOT Products, CME products and products of any other exchange for which CME provides clearing services or linked clearing. 

Authority Over Clearing Firm Margin Requirements.    CME will work with CBOT to develop a coordinated performance bond / margin review process
such that CME can receive input from CBOT as to performance bond / margin requirements. Such process shall involve monthly meetings with representatives designated by CBOT and will involve data
analysis and discussions with respect to how and when to implement changes to clearing firm level performance bond / margin requirements; provided however, that ultimate control over performance bond
/ margin requirements at the clearing member level shall reside with CME. Notwithstanding the foregoing, CME agrees that determinations by CME with respect to performance bond / margin requirements
for CBOT Core Products shall be made strictly on the basis of risk management principles and shall not involve competitive considerations associated with CME products and competing CBOT Products.
Additionally, CME shall not recognize clearing member level spreads between CBOT Products and products of any other exchange without the prior written approval of CBOT. 

Authority Over Customer Level Requirements.    CBOT shall have ultimate control over customer level exchange minimum performance bond / margin
and spread requirements, provided that CBOT shall consult with CME as to such requirements as a part of the coordinated review process to be developed between CME and CBOT. 

Acceptable Collateral.    CME will review the forms of collateral currently accepted by BOTCC that are not currently accepted by CME and,
where in CME's judgment such additional forms of collateral are frequently used and not unduly costly or risky to accept, CME will amend the CME Rules to accept such forms of collateral with respect
to CBOT Products. Notwithstanding the foregoing, CME will conduct this review process prior to the Launch Date only if time permits. 

Transfers.    CME shall effect the transfer of positions in CBOT Products between Special CME Clearing Members, where applicable, in
accordance with the CME Rules and Operational Policies and Procedures in effect from time to time. Transferred positions will be guaranteed by CME to the 

A-2

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

transferee
only upon payment of initial settlement variation and performance bond by the transferor or the transferee, as applicable. 

Give-Up Transactions.    CME will make the allocate claim system ("ACS") available to Special CME Clearing Members for processing
give-up transactions. 

Exercise and Assignment.    CME will provide exercise and assignment functionality to Special CME Clearing Members with respect to positions
in options products, including at option expiration, as set forth in the CME Rules and the Operational Policies and Procedures. CME will not support option expiration processing on Saturdays, and
option expiration processing for CBOT Products as of the Launch Date will be completed on Fridays (or another business day, with respect to Friday holidays) in accordance with the CME Rules and the
Operational Policies and Procedures. 

Deliveries.    CME will provide automated support to CBOT in connection with deliveries management of CBOT Products, including inventory of
deliverable positions, inventory of deliverable supply, delivery intent processing, delivery assignment, and delivery invoicing, except that CBOT shall maintain responsibility for management and
operation of the registration and delivery process. CME will provide automated deliveries support as of the Launch Date of financial and equity CBOT Products that are listed for trading by CBOT as of
the Effective Date. CME will use its best efforts to implement automated deliveries support of other CBOT Products that are listed for trading by CBOT as of the Effective Date, including agricultural
products, as of the Launch Date or as soon thereafter as is practicable. CME shall provide automated deliveries support for new CBOT Products (or for changed features of existing CBOT Products) listed
for trading by CBOT after the Effective Date, provided that the product characteristics permit automation of deliveries management through means substantially similar to those that CME then employs
with respect to other products cleared by CME. If significant development work will be required by CME to provide automated deliveries support for such products listed for trading by CBOT after the
Effective Date, the work will be subject to the change request procedures set forth in Section 3.10. 

Settlement Banks.    CME will interface with all banks that serve as settlement banks for transactions in CME products to provide settlement
services for transactions in CBOT Products also, provided that such banks agree to serve as settlement banks for transactions in CBOT Products. Additionally, CME will use best efforts to establish a
settlement bank relationship with Lakeside Bank and, as appropriate, Burling Bank, prior to the Launch Date. 

Large Trader Reports.    CME will collect on CBOT's behalf the large trader submissions from Special CME Clearing Members or their clients and
forward such submissions to the CFTC and to CBOT for regulatory purposes. The CME clearing house shall be authorized to use this data to perform the type of account level stress testing it performs on
its own products to identify concentration of client exposure at a clearing member. CME shall facilitate reporting of large trader data for CBOT products by accepting transmissions of such data in
standard formats. CME shall construct an application that maintains a database of firms, customer accounts, and EINs (the term CBOT uses for the number used to aggregate customer accounts by
beneficial owner). For each reported position, the application shall search in the database by the firm and customer account: a) if the firm and customer account is found, the application shall
tag the position with the EIN for it; and b) if the firm and customer account is not found, the application shall assign the EIN, using CBOT's standard convention, and tag the position with the
newly-assigned EIN. The application shall then prepare a datafile of reported positions for transmission to CBOT, with each position tagged with its EIN.
The application shall further provide CBOT staff with an interface for viewing and modifying the EIN assigned to a particular firm and customer account. CBOT shall provide an initial datafile or files
for loading this application with its existing EINs and their associated firm and customer accounts. CME shall prepare position limit reports against the large trader data for provision to CBOT. Other
than these enumerated processes, all 

A-3

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

responsibility
for large trader reporting analysis and other larger trader-related functions remains with CBOT. 

Calculation and Collection of Fees.    CME will calculate, bill and collect clearing fees from Special CME Clearing Members for transactions
in CBOT Products, using the transaction types for which CME currently bills clearing members with respect to transactions in its own products. The rate billed will be determined by CBOT for the fee
for initial cleared transactions, including block trades, EFPs and other alternative execution procedures, and by CME for post-trade transaction types (including, without limitation,
give-ups, transfers, option exercise and assignment, and deliveries). 

Operational Timeline.    Except as otherwise set forth in the CME Rules or the Operational Policies and Procedures, the operational timeline
for clearing services and submission of reports for transactions and positions in CBOT Products shall be the same as it is with respect to transactions and positions for CME products. CME anticipates
using single, combined clearing process cycles for both CME products and CBOT Products. Consequently, CME's deadlines and requirements shall apply with respect to processes including, but not limited
to, trade report submission deadlines, out-trade report production, final reconciliation and option exercise deadlines, mark-to-market and settlement cycles
(including intra-day cycles), collateral substitution and withdrawal deadlines, and pay/collect procedures. 

Support for Existing and Future CBOT Product Characteristics.    Subject to any specific limitations set forth in this Schedule A or
elsewhere in this Agreement, in providing the Clearing Services CME will develop systems and adopt practices as necessary to support the product features and characteristics of CBOT products as they
are listed for trading as of the Effective Date, including, without limitation, fractional price formats and variable cabinet pricing. CME shall similarly support new product features and
characteristics of existing CBOT Products or those that CBOT may list for trading in the future, provided, however, that if the features and characteristics of such products differ materially from
those of products then cleared by CME, CME's support of such new product features or characteristics shall be subject to the change request procedures set forth in Section 3.10. 

Security Deposit Management and Assessment.    CME will calculate and collect from Special CME Clearing Members security deposit contributions
in accordance with the CME Rules and the Operational Policies and
Procedures in effect from time to time. CME shall have the authority, as set forth in the CME Rules and the Operational Policies and Procedures in effect from time to time, to seize the security
deposits of Special CME Clearing Members and to further exercise certain limited assessment powers in the event of a default by either a Special CME Clearing Member or a CME clearing member. For the
avoidance of doubt, CME shall manage a joint security deposit pool for the benefit of Special CME Clearing Members and CME clearing members with respect to transactions in CME products, transactions
in CBOT Products, and transactions in the products of any other exchange for which CME provides clearing services or linked clearing, unless CME's agreement with such other exchange prohibits a joint
guarantee fund. Consequently, the security deposit contributions of CME-only clearing members may be assessed as a result of defaults as to transactions in CBOT Products, and the
contributions of CBOT-only clearing members who are Special CME Clearing Members may be assessed as a result of defaults as to transactions in CME products. 

Support for Cross-Margining of CBOT Products.    CME will provide support for and will participate in cross-margining of positions in CBOT
Products held by Special CME Clearing Members pursuant to CBOT's existing cross-margining arrangements with GSCC and OCC, provided that CBOT shall secure any necessary amendments to substitute CME for
BOTCC in its current cross-margining agreements with GSCC and OCC. CME will provide support for and will participate in cross-margining of positions in CBOT Products held by Special CME Clearing
Members under any other cross-margining agreements (or amendments to existing agreements) into which CBOT may enter in the future, provided that (i) such support, including without limitation
the development of necessary interfaces, shall be subject to the change request procedures set forth in Section 3.10, and (ii) CME may decline 

A-4

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

to
support such cross-margining agreement if CME concludes, in its sole reasonable judgment after consultation and negotiation with CBOT and the other party, that such proposed cross-margining
arrangement presents an unacceptable credit risk to CME. 

Information and Reports for CBOT.    With respect to each trading day, CME will deliver to CBOT the following reports in accordance with the
Operational Policies and Procedures: 

	a.
	End-of-day
volume and open interest file;

	b.
	End-of-day
transaction listing file; and

	c.
	Large
trader data file as submitted by Clearing Members 

Information and Reports From CBOT.    CBOT (or a third-party service provider to CBOT, if CBOT delegates such obligation) shall provide the
following reports and information to CME in accordance with the Operations Policies and Procedures: 

	a.
	A
daily data file of the CBOT Products eligible for trading on the next business day;

	b.
	Information
on the performance bond requirements CBOT sets for the customer level exchange minimum requirements, which must be provided at least three to five business days prior to
their effective date except in situations where changes are driven by unusual market volatility. Such data is required in order for CME to produce the appropriate customer level SPAN files;

	c.
	A
daily data file of eligible CBOT traders for the next trading day, together with identification of each trader's guarantor Special CME Clearing Member;

	d.
	Two-sided
matched trade record messages, in near real time, for trades executed electronically on LIFFE Connect;

	e.
	One-sided
(unmatched) trade record messages, in near real time, from any electronic trading floor technology devices where CBOT rather than the Special CME Clearing Members
will be the source of the trade data;

	f.
	Two-sided
matched trade messages in near real time for any pit trades matched by any trade matching system for such trades as CBOT may implement;

	g.
	Real
time quote stream of CBOT prices for real-time clearing house and Special CME Clearing Member risk management; and

	h.
	End
of day settlement prices received both via a datafile and via the real time quote stream to be received by approximately 2:30-2:45 p.m. for products that settle
by 2:00 p.m. and by approximately 3:45-4:00 p.m. for products that settle later than 2:00 p.m. The purpose of receiving such end-of-day
settlement prices in a timely manner is to facilitate the timely publication of daily SPAN files for CBOT Products and to allow Clearing Members to begin bookkeeping processing in a timely manner. 

Information and Reports for Clearing Members.    CME will make available to each Special CME Clearing Member on every business day the
following information, in machine readable format in accordance with the CME Rules and the Operational Policies and Procedures: 

	a.
	futures
and options transactions accepted by CME for each account of the Special CME Clearing Member;

	b.
	obligations
to receive or deliver products or instruments underlying matured physically settled futures contracts in the Special CME Clearing Member's accounts; 

A-5

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

	c.
	give-up
trades, position transfers and other transactions in the Special CME Clearing Member's accounts involving CBOT Products;

	d.
	EFP
transactions, which will be identified as such by CME using an available "data field" when such transactions are identified as such to CME by CBOT or Special CME Clearing Members;

	e.
	block
trades, which will be identified as such by CME using an available "data field" when such transactions are identified as such to CME by CBOT or Special CME Clearing Members;

	f.
	the
daily mark-to-market of each open position in futures held by each Special CME Clearing Member; and

	g.
	amounts
of money due to and from CME from and to each Special CME Clearing Member for each account held by the Special CME Clearing Member with CME. 

File Formats Generally.    The formats for data files and/or messages to be exchanged among CME, CBOT, any third-party service provider to
CBOT or any other entity with which CME must exchange data in connection with providing Clearing Services, shall be as mutually agreed by CME and CBOT promptly after the execution of this Agreement.
If any disagreement arises, generally the principle that the receiving party specifies the format shall control. 

Special CME Clearing Member Access to CME Clearing Systems.    CME will permit Special CME Clearing Members to access CME's automated and
online systems for all clearing and position management functionality for use in connection with positions in CBOT Products on substantially the same basis as CME permits such access with respect to
positions in its own products (unless unique characteristics of a particular CBOT Product preclude use of such functionality). 

Services Complete.    Except as otherwise specified in this Agreement, in the CME Rules or the Operational Policies and Procedures, the
services set forth above are the complete clearing services that CME will provide to CBOT pursuant to this Agreement. Without limiting the generality of the foregoing, CBOT understands that CME will
not provide additional services relating to market regulation, generating statistical information, managing time and sales information, managing membership requirements, or daily bulletin processing. 

A-6

   
Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

Schedule B  

***** 

B-1

   
Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

Schedule C

 Project Development Plan  

        Outlined below are the terms to which the Parties have agreed concerning the development of and compliance with a detailed project plan for
implementing the arrangements described in this Agreement. 

Terms Relating to Plan  

        A.    Development of the Plan.    Immediately following the Effective Date of this Agreement and on an ongoing basis
throughout the development period prior to the Launch Date, the Parties will use their best efforts to update the project development plan (the "Plan", as updated from time to time during the
development period). The Plan shall identify, with reasonable detail, (i) all material information that must be exchanged between the Parties, (ii) any outstanding matters that must be
agreed to between the Parties or decisions that must be reached by one Party, (iii) all material tasks that must be completed by either Party, and (iv) the timeline upon which such tasks
must be completed in order to meet the Launch Date. The Parties shall also use their best efforts to jointly develop and incorporate within the Plan an (i) outline and timeline for completing
legal documentation, including necessary regulatory filings and any documentation that must be executed by Special CME Clearing Members or other entities, and (ii) and outline and timeline for
other communications with Special CME Clearing Members, ISVs, market data vendors, back-office service bureaus and any other entity with which information must be shared in order to
effectuate a successful launch of Clearing Services. 

        B.    Mutual Best Efforts to Participate and Adhere to Plan.    Each of the Parties shall use its best efforts to
participate fully in the planning process and to complete its required tasks in accordance with the timeline identified in the Plan. CME understands and agrees that it has primary responsibility for
completing the development work necessary to implement Clearing Services as described in Schedule A. CBOT understands and agrees that it also will have development work to complete in order to
effectively implement Clearing Services, including without limitation any development work necessary to
provide to CME the information and reports specified to be provided by CBOT in Schedule A. Both Parties understand and agree that their full participation will be required for multiple phases
of systems testing, including a comprehensive end-to-end testing phase of the fully integrated systems, which testing may require overtime, weekend and holiday work. 

        C.    Failure to Adhere to Plan.    A failure to meet a particular internal deadline set forth in the Plan by either
Party shall not be deemed a Material Breach of this Agreement. However, if either Party concludes that a serious failure or multiple failures to conform to the tasks and timelines set forth in the
Plan jeopardizes the Parties' ability to meet the Launch Date, the concerned Party shall so notify the relevant management personnel of the other Party (including the individuals identified in
Section 19.5) in writing, which may be by e-mail, and the Parties shall use reasonable efforts to resolve the matter and adjust the Plan to the concerned Party's satisfaction. If
such efforts are not successful, the concerned Party may, not sooner than ten (10) business days after delivering the notice, submit the matter to arbitration. If the arbitrator concludes that
one of the Parties is primarily and substantially at fault for the failure and that the failure does jeopardize the Launch Date, the other Party shall have the option to terminate this Agreement for
an Unexcused Breach under Section 10.1, without application of any notice and cure period. 

C-1

 

Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks ("*****"),
and the omitted text has been filed separately with the Securities and Exchange Commission. 

Project Review Teams  

        Immediately following the Effective Date, each Party will identify individuals to participate in the following review teams, each of which will review matters
assigned to it and develop any related elements of the Plan. Where a team is assigned to identify interface requirements or other technical requirements, the team shall produce at least a
high-level functional specifications document. The Parties agree that the project review teams shall complete the process of fully defining requirements for each aspect of the project
described below by May 16, 2003, meaning that the teams will have decided how to resolve any open issues and have documented and circulated their assigned elements of the Plan, including any
functional specifications documents. 

        A.    Product Review Team.    Matters to review: 

	

	Review
contract specifications in detail

	

	Identify
specifications not currently supported by CME

	

	Document
variable cabinet pricing requirements

	

	Review
product and price file layouts

	

	Identify
product and price interface requirements

	

	Review
market related layouts

	

	Map
MD layouts

	

	Identify
MD interface requirements 

        B.    Deliveries Review Team.    Matters to review: 

	

	Review
delivery requirements

	

	Determine
information that must be shared to complete automated deliveries processes development work

	

	Review
deliveries file layouts

	

	Identify
deliveries interface requirements 

        C.    Regulatory Review Team.    Matters to review: 

	

	Review
regulatory file layouts

	

	Identify
regulatory interface requirements 

        D.    Membership Review Team.    Matters to review: 

	

	Review
membership file layouts

	

	Identify
membership interface requirements 

        E.    Trade Review Team.    Matters to review: 

	

	Review
trade related file layouts

	

	Map
trade layouts

	

	Identify
trade interface requirements 

C-2

QuickLinks

CLEARING SERVICES AGREEMENT EFFECTIVE THE 16th DAY OF APRIL 2003QuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.4  

  
 

    AGREEMENT    
    

        THIS AGREEMENT, made and entered into this 10th day of July 2003, by and between CHICAGO MERCANTILE EXCHANGE INC. ("Employer" or
"CME"), a Delaware Business Corporation, having its principal place of business at 30 South Wacker Drive, Chicago, Illinois, and David Gomach ("Employee"). 

R E C I T A L S:  

        WHEREAS, Employer wishes to retain the services of Employee in the capacity of Managing Director, Chief Financial Officer, upon the terms and conditions
hereinafter set forth and Employee wishes to accept such employment; 

        NOW,
THEREFORE, in consideration of the mutual promises contained herein, the parties mutually agree as follows: 

	1)
	Employment.    Subject to the terms of the Agreement, Employer hereby agrees to employ Employee during the Agreement Term as
Managing Director, Chief Financial Officer, and Employee hereby accepts such employment. Employee shall report to the Employer's Chief Executive Officer. The duties of Employee shall include, but not
be limited to, the performance of all duties associated with executive oversight and management of the Employer's Finance Division. Employee shall devote his full time, ability and attention to the
business of Employer during the Agreement Term, subject to the direction of the Chief Executive Officer. 

Notwithstanding
anything to the contrary contained herein, nothing in the Agreement shall preclude Employee from participating in the affairs of any governmental, educational or other charitable
institution, engaging in professional speaking and writing activities, and serving as a member of the board of directors of a publicly held corporation (except for a competitor of Employer), provided
Employee notifies the Employer's Board of Directors ("Board") prior to his participating in any such activities and as long as the Board does not determine that any such activities interfere with or
diminish Employee's obligations under the Agreement. Employee shall be entitled to retain all fees,
royalties and other compensation derived from such activities, in addition to the compensation and other benefits payable to him under the Agreement, but shall disclose such fees to Employer. 

	2)
	Agreement Term.    Employee shall be employed hereunder for a term commencing on January 1, 2003, and expiring on
December 31, 2005, unless sooner terminated as herein provided ("Agreement Term"). The Agreement Term may be extended or renewed only by the mutual written agreement of the parties.

	3)
	Compensation.

	(a)
	Base Salary.    Beginning February 23, 2003 and during the remainder of the Agreement Term, the Employer shall pay to
Employee a base salary at a rate of not less than $250,000.00 per annum ("Base Salary"), payable in accordance with the Employer's normal payment schedule.

	(b)
	Bonuses.    Any bonus during the Agreement Term shall be provided at the sole discretion of the Employer.

	4)
	Benefits.    Employee shall be entitled to insurance, vacation and other employee benefits commensurate with his position in
accordance with Employer's policies for executives in effect from time to time. Employee acknowledges receipt of a summary of Employer's employee benefits policies in effect as of the date of this
Agreement.

	5)
	Expense Reimbursement.    During the Agreement Term, Employer shall reimburse Employee, in accordance with Employer's policies
and procedures, for all proper expenses incurred by him in the performance of his duties hereunder. 

 
	6)
	Termination.

	a)
	Death.    Upon the death of Employee, this Agreement shall automatically terminate and all rights of Employee and his heirs,
executors and administrators to compensation and other benefits under this Agreement shall cease, except for compensation which shall have accrued to the date of death, including accrued Base Salary,
and other employee benefits to which Employee is entitled upon his death, in accordance with the terms of the plans and programs of CME.

	b)
	Disability.    Employer may, at its option, terminate this Agreement upon written notice to Employee if Employee, because of
physical or mental incapacity or disability, fails to perform the essential functions of his position required of him hereunder for a continuous period of 90 days or any 120 days within
any 12-month period. Upon such termination, all obligations of Employer hereunder shall cease, except for payment of accrued Base Salary, and other employee benefits to which Employee is
entitled upon his termination hereunder, in accordance with the terms of the plans and programs of CME. In the event of any dispute regarding the existence of Employee's disability hereunder, the
matter shall be resolved as follows: (1) by the determination of a physician selected by the Chief Executive Officer of the Employer; (2) Employee shall have the right to challenge that
determination by presenting a contrary determination from a physician of his choice; (3) in such event, a physician selected by agreement of the Employee and the Chief Executive Officer of the
Employer will make the final determination. The Employee shall submit to appropriate medical examinations for purposes of making the medical determinations hereunder.

	c)
	Cause.    Employer may, at its option, terminate Employee's employment under this Agreement for Cause. As used in this
Agreement, the term "Cause" shall mean any one or more of the following:

	(1)
	any
refusal by Employee to perform his duties and responsibilities under this Agreement, as determined after investigation by the Board. Employee, after having been given written
notice by Employer, shall have seven (7) days to cure such refusal;

	(2)
	any
intentional act of fraud, embezzlement, theft or misappropriation of Employer's funds by Employee, as determined after investigation by the Board, or Employee's admission or
conviction of a felony or of any crime involving moral turpitude, fraud, embezzlement, theft or misrepresentation;

	(3)
	any
gross negligence or willful misconduct of Employee resulting in a financial loss or liability to the Employer or damage to the reputation of Employer, as determined after
investigation by the Board;

	(4)
	any
breach by Employee of any one or more of the covenants contained in Section 7, 8 or 9 hereof;

	(5)
	any
violation of any rule, regulation or guideline imposed by CME or a regulatory or self regulatory body having jurisdiction over Employer, as determined after investigation by the
Board. 

The
exercise of the right of CME to terminate this Agreement pursuant to this Section 6(c) shall not abrogate any other rights or remedies of CME in respect of the breach giving rise to such
termination. 

If
Employer terminates Employee's employment for Cause, Employee shall be entitled to accrued Base Salary through the date of the termination of his employment, other employee benefits to which
Employee is entitled upon his termination of employment with Employer, in accordance with the terms of the plans and programs of CME. Upon termination for cause, 

2

 

Employee
will forfeit any unvested or unearned compensation or long-term incentives, unless otherwise provided herein or specified in the terms of the plans and programs of CME. 

	d)
	Termination Without Cause.    Upon 30 days prior written notice to Employee, Employer may terminate this Agreement for
any reason other than a reason set forth in sections (a), (b) or (c) of this Section 6. If, during the Agreement Term, Employer terminates the employment of Employee hereunder for
any reason other than a reason set forth in subsections (a), (b) or (c) of this Section 6:

	(1)
	Employee
shall be entitled to receive accrued Base Salary through the date of the termination of his employment, and other employee benefits to which Employee is entitled upon his
termination of employment with Employer, in accordance with the terms of the plans and programs of Employer; and

	(2)
	a
one time lump sum severance payment equal to 24 months of his Base Salary, as defined herein, as of the date of the Employee's termination.

	e)
	Voluntary Termination.    Upon 60 days prior written notice to CME (or such shorter period as may be permitted by CME),
Employee may voluntarily terminate his employment with CME prior to the end of the Agreement Term for any reason. If Employee voluntarily terminates his employment pursuant to this subsection (e), he
shall be entitled to receive accrued Base Salary through the date of the termination of his employment and other employee benefits to which Employee is entitled upon his termination of employment with
CME, in accordance with the terms of the plans and programs of CME.

	7)
	Confidential Information.    Employee acknowledges that the successful development of CME's services and products, including
CME's trading programs and systems, current and potential customer and business relationships, and business strategies and plans requires substantial time and expense. Such efforts generate for CME
valuable and proprietary information ("Confidential Information") which gives CME a business advantage over others who do not have such information. Confidential Information includes, but is not
limited to the following: trade secrets, technical, business, proprietary or financial information of CME not generally known to the public, business plans, proposals, past and current prospect and
customer lists, trading methodologies, systems and programs, training materials, research data bases and computer software; but shall not include information or ideas acquired by Employee prior to his
employment with CME if such pre-existing information is generally known in the industry and is not proprietary to CME.

	(a)
	Employee
shall not at anytime during the Agreement Term or thereafter, make use of or disclose, directly or indirectly to any
competitor or potential competitor of CME, or divulge, disclose or communicate to any person, firm, corporation, or other legal entity in any manner whatsoever, or for his own benefit and that of any
person or entity other than Employer, any Confidential Information. This subsection shall not apply to the extent Employee is required to disclose Confidential Information to any regulatory agency or
as otherwise required by law; provided, however, that Employee will promptly notify Employer if Employee is requested by any entity or person to divulge Confidential Information, and will use his best
efforts to ensure that Employer has sufficient time to intervene and/or object to such disclosure or otherwise act to protect its interests. Employee shall not disclose any Confidential Information
while any such objection is pending.

	(b)
	Upon
termination for any reason, Employee shall return to Employer all records, memoranda, notes, plans, reports, computer tapes and equipment, software and other documents or data
which constitute Confidential Information which he may then possess or have under his control (together with all copies thereof) and all credit cards, keys and other materials and equipment which are
Employer's property that he has in his possession or control. 

3

 

	(c)
	If,
at any time of enforcement of this Section 7, a court holds that the restrictions stated herein are unreasonable, the parties hereto agree that a maximum period, scope or
geographical area reasonable under the circumstances shall be substituted for the stated period, scope or area and that the court shall be allowed to revise the restrictions contained herein to cover
the maximum period, scope and area permitted by law.

	8)
	Non-solicitation.

	(a)
	General.    Employee acknowledges that Employer invests in recruiting and training, and shares Confidential Information with,
its employees. As a result, Employee acknowledges that Employer's employees are of special, unique and extraordinary value to Employer.

	(b)
	Non-solicitation.    Employee further agrees that for a period of one year following the termination of his
employment with CME for any reason he shall not in any manner, directly or indirectly, induce or attempt to induce any employee of CME to terminate or abandon his or her employment with CME for any
purpose whatsoever.

	(c)
	Reformation.    If, at any time of enforcement of this Section 8, a court holds that the restrictions stated herein
are unreasonable, the parties hereto agree that the maximum period, scope or geographical area reasonable under the circumstances shall be substituted for the stated period, scope or area and that the
court shall be allowed to revise the restrictions contained herein to cover the maximum period, scope and area permitted by law.

	9)
	Intellectual Property.    During the Agreement Term, Employee shall disclose to CME and treat as confidential information all
ideas, methodologies, product and technology applications that he develops during the course of his employment with CME that relates directly or indirectly to CME's e-commerce business or
any other CME business. Employee hereby assigns to CME his entire right, title and interest in and to all discoveries and improvements, patentable or otherwise, trade secrets and ideas, writings and
copyrightable material, which may be conceived by Employee or developed or acquired by him during his employment with CME, which may pertain directly or indirectly to the business of the CME. Employee
shall at any time during or after the Agreement Term, upon CME's request, execute, acknowledge and deliver to CME all instruments and do all other acts which are necessary or desirable to enable CME
to file and prosecute applications for, and to acquire, maintain and enforce, all patents, trademarks and copyrights in all countries with respect to intellectual property developed or which was being
developed during Employee's employment with CME.

	10)
	Remedies.    Employee agrees that given the nature of CME's business, the scope and duration of the restrictions in
paragraphs 7, 8 and 9 are reasonable and necessary to protect the legitimate business interests of CME and do not unduly interfere with Employee's career or economic pursuits. Employee
recognizes and agrees that a breach of any or all of the provisions of Sections 7, 8 and 9 will constitute immediate and irreparable harm to CME's business advantage, for which damages cannot
be readily calculated and for which damages are an inadequate remedy. Accordingly, Employee acknowledges that CME shall therefore be entitled to seek an injunction or injunctions to prevent any breach
or threatened breach of any such section. Such injunctive relief shall not be Employer's sole remedy. Employee agrees to reimburse CME for all costs and expenses, including reasonable attorney's fees
and costs, incurred by CME in connection with the successful enforcement of its rights under Sections 7, 8 and 9 of this Agreement.

	11)
	Survival.    Sections 7, 8, 9 and 10 of this Agreement shall survive and continue in full force and effect in
accordance with their respective terms, notwithstanding any termination of the Agreement. 

4

 
	12)
	Arbitration.    Except with respect to Sections 7, 8, and 9, any dispute or controversy between CME and Employee,
whether arising out of or relating to this Agreement, the breach of this Agreement, or otherwise, shall be settled by arbitration in Chicago, Illinois, in accordance with the following:

	(a)
	Arbitration
hearings will be conducted by the American Arbitration Association (AAA). Except as modified herein, arbitration hearings will be conducted in accordance with AAA's rules.

	(b)
	State
and federal laws contain statues of limitation which prescribe the time frames within which parties must file a law suit to have their disputes resolved through the court
system. These same statutes of limitation will apply in determining the time frame during which the parties must file a request for arbitration.

	(c)
	If
Employee seeks arbitration, Employee shall submit a filing fee to the AAA in an amount equal to the lesser of the filing fee charged in the state or federal court in Chicago,
Illinois. The AAA will bill Employer for the balance of the filing and arbitrator's fees.

	(d)
	The arbitrator
shall have the same authority to award (and shall be limited to awarding) any remedy or relief that a court of competent jurisdiction could award, including compensatory
damages, attorney fees, punitive damages and reinstatement. Employer and Employee may be represented by legal counsel or any other individual at their own expense during an arbitration hearing.

	(e)
	Judgment
on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.

	(f)
	Except
as necessary in court proceedings to enforce this arbitration provision or an award rendered hereunder, or to obtain interim relief, neither a party nor an arbitrator may
disclose the existence, content or results of any arbitration hereunder without the prior written consent of CME and Employee.

	13)
	Notices.    All notices and other communications required or permitted hereunder shall be in writing and shall be deemed
given when (i) delivered personally or by overnight courier to the following address of the other party hereto (or such other address for such party as shall be specified by notice given
pursuant to this Section) or (ii) sent by facsimile to the following facsimile number of the other party hereto (or such other facsimile number for such party as shall be specified by notice
given pursuant to this Section), with the confirmatory copy delivered by overnight courier to the address of such party pursuant to this Section 13: 

If
to CME, to: 

James
McNulty

President and Chief Executive Officer

Chicago Mercantile Exchange

30 S. Wacker

Chicago, IL 60606

(312) 930-3100 

If
to Employee, to: 

David
Gomach

600 East Carrington Lane

Appleton, WI 54913 

	14)
	Severability.    Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under applicable law or rule in any 

5

 

jurisdiction,
such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of any other provision of this Agreement or the validity, legality or
enforceability of such provision in any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had
never been contained herein. 

	15)
	Entire Agreement.    This Agreement constitutes the entire Agreement and understanding between the parties with respect to
the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations by or between the parties, written or oral, which may have related in any manner to the
subject matter hereof. No other agreement or amendment to this Agreement shall be binding upon either party including, without limitation, any agreement or amendment made hereafter unless in writing,
signed by both parties. Employee acknowledges that each of the parties has participated in the preparation of this Agreement and for purposes of principles of law governing the construction of the
terms of this Agreement, no party shall be deemed to be the drafter of the same.

	16)
	Successors and Assigns.    This Agreement shall be enforceable by Employee and his heirs, executors, administrators and legal
representatives, and by CME and its successors and assigns.

	17)
	Governing Law.    This Agreement shall be governed by and construed and enforced in accordance with the internal laws of the
State of Illinois without regard to principles of conflict of laws.

	18)
	Acknowledgment.    Employee acknowledges that he has read, understood, and accepts the provisions of this Agreement.

        IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above. 

	
Chicago Mercantile Exchange Inc.	
 	

David Gomach
	

By:	

/s/  JAMES J. MCNULTY      
	
 	

/s/  DAVID GOMACH      

	

Date:	

	
 	

Date:	

6

QuickLinks

AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00054-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00054-of-00352.parquet"}]]